← All Signals

🏥 FDA: K.C. Pharmaceuticals, Inc — Class II

healthcareactionableSource: FDA
95%Confidence
0Views
FDASource
2026-04-18Date

Summary

K.C. Pharmaceuticals' sterility problems extend to tetrahydrozoline eye drops, affecting major retailers like Walgreens. This represents a significant quality control failure across multiple product lines and formulations.

Actionable: Audit all eye care products from K.C. Pharmaceuticals and implement enhanced quality checks for similar OTC products.

AI Confidence: 95%

Data Points

firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productSterile Eye Drops ORIGINAL FORMULA (tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15mL) bottles; a) Good Sense Sterile Eye Drops, Distributed By: Perrigo Di

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now